Trump signs order fast tracking review of psychedelics for mental health disorders
federal funds to make them more accessible, and ordered the Food and Drug Administration to fast track a review of such drugs as psilocybin and ibogaine.
[](https://www.npr.org/2026/03/09/nx-s1-5735927/can-psychedelic-therapy-go-mainstream)